Janux Therapeutics JANX Cash Flow Statement (2020-2026)

NASDAQ JANX
$20.24 +0.44 (+2.22%)
As of: Sep 4, 2026 · 3:59 PM EDT
Reported Financials

Janux Therapeutics Quarterly Cash Flow Statement

Periods 25 quarters
Latest Jun 2026

Janux Therapeutics reported cash from operations of $12.48M and free cash flow of $13.35M for the quarter ended Jun 2026, up 152.4% year over year. This cash flow statement covers 25 quarters of results from Jun 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-10.77M-13.42M-13.41M-16.89M-16.70M-16.07M-17.46M-17.51M-11.57M-11.76M-14.76M-5.96M-28.06M-20.22M-23.51M-33.86M-24.31M-31.95M-24.36M-21.97M
Share-based Compensation
5.55M2.94M7.12M7.55M7.59M4.21M8.89M9.08M8.50M4.48M9.85M9.66M15.39M6.25M10.70M10.96M61.20M9.52M10.39M52.30M
Cash from Operations
-5.85M-10.48M-11.52M-6.07M-13.41M-11.91M-13.91M-15.05M-11.71M-9.90M-14.84M-10.02M-2.23M-16.73M-17.02M-23.81M-12.86M-28.54M-12.34M12.48M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles
0.08M0.06M0.02M0.10M0.77M1.29M1.68M1.84M2.11M2.06M1.79M2.97M2.90M2.93M4.22M5.21M4.62M3.52M2.62M2.89M
Change in Working Capital
Change in Receivables
-0.38M0.50M-0.50M0.75M-0.75M0.52M6.98M35.00M-34.85M
Change in Account Payables
2.58M-0.48M-0.74M0.86M-0.63M0.22M-0.11M-0.17M0.23M0.33M-0.46M-0.69M1.18M1.56M-1.64M1.11M-0.17M1.67M-1.61M-0.34M
Change in Accured Expenses
0.41M1.92M1.16M-0.89M2.89M1.00M-0.56M1.44M-1.99M0.43M-1.57M3.06M4.57M-1.63M1.73M2.89M6.18M-4.52M-2.03M4.04M
Other Working Capital Changes
0.04M-3.97M1.40M3.40M-0.94M-0.49M-1.65M-0.33M-2.00M-1.94M1.17M1.76M0.14M0.20M0.70M0.35M-0.45M0.23M46.27M-10.12M
Investing Activities
Capital Expenditures
0.62M0.63M0.97M0.90M2.52M2.06M0.40M0.65M0.29M0.52M0.20M0.10M0.03M0.06M0.37M0.47M0.09M0.11M1.34M-0.86M
Change in Acquisitions & Divestments
22.14M112.00M77.10M78.75M116.75M86.50M63.25M95.00M75.00M44.75M65.00M44.75M45.16M58.00M31.27M94.72M126.37M152.93M121.31M106.26M
Cash from Investing Activities
-205.54M7.33M31.07M9.04M19.76M-1.60M-8.74M17.87M-61.45M11.12M-113.74M-190.88M12.67M33.93M-340.39M1.56M8.31M29.54M8.29M-38.78M
Financing Activities
Other financing activities
-0.84M1.58M1.66M0.90M3.54M
Debt Issuance and Repayment
Long-Term Debt Issuances
Change in Capital Stock
Net Shares Issued and Repurchased
5.23M1.61M2.25M1.73M2.02M2.09M2.36M1.33M1.73M1.72M
Misc.
Cash from Financing Activities
-0.84M0.16M0.00M0.31M0.19M1.58M0.53M56.61M0.83M322.17M2.77M1.65M386.65M0.55M0.95M0.49M2.94M3.54M2.24M
Change in Cash
-212.24M-2.99M19.55M3.27M6.35M-13.33M-21.07M3.35M-16.55M2.05M193.60M-198.14M12.09M403.85M-356.86M-21.30M-4.06M3.94M-0.51M-24.06M
Free Cash Flow
-6.47M-11.11M-12.49M-6.97M-15.93M-13.97M-14.31M-15.70M-12.00M-10.42M-15.03M-10.12M-2.26M-16.78M-17.39M-24.29M-12.95M-28.65M-13.67M13.35M
Net Cash Flow
-212.24M-2.99M19.55M3.27M6.35M-13.33M-21.07M3.35M-16.55M2.05M193.60M-198.14M12.09M403.85M-356.86M-21.30M-4.06M3.94M-0.51M-24.06M